Artivion | CRY - Current Liabilities

Stock Price
38.33
Daily Change
0.33 0.87%
Monthly
-13.50%
Yearly
35.63%
Q1 Forecast
37.14

Artivion reported $85.84M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
Accuray USD 194.61M 2.03M Sep/2025
AngioDynamics USD 77.97M 10.62M Feb/2025
Artivion USD 85.84M 19.17M Sep/2025
AtriCure USD 81.52M 3.68M Dec/2025
Baxter International USD 2.97B 805M Dec/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Boston Scientific USD 5.44B 111M Dec/2025
Edwards Lifesciences USD 1.59B 183.3M Sep/2025
Inogen USD 64.94M 2.12M Sep/2025
Integra LifeSciences USD 364.05M 565.75M Sep/2025
J&J USD 54.13B 3.26B Dec/2025
Mesa Laboratories USD 54.4M 6.1M Dec/2025
Orthofix International USD 159.85M 11.47M Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
ResMed USD 1.25B 7.39M Dec/2025
Stryker USD 7.79B 380M Dec/2025
Surmodics USD 20.54M 347K Sep/2024
Tandem Diabetes Care USD 242.72M 9.82M Dec/2025
Teleflex USD 773.03M 56.88M Sep/2025
Terumo JPY 539.7B 243.4B Dec/2025
Trinity Biotech USD 34.49M 2.97M Sep/2025